Ingredients & evidence
Arialief: a closer look at its ingredients and the available research
What does the supplied ingredient panel list, what have researchers actually studied, and where does the evidence stop? CorePeak Nutrition reviews the sources and the information to check before purchasing.
This is an advertisement, not an independent review. The publisher may receive compensation from purchases through links on this page. Advertising disclosure.
Arialief is marketed as a dietary supplement in capsule form. Evaluating it starts with the current label: the ingredients, their amounts and the evidence relevant to that specific formulation.
This advertorial compares the supplied ingredient panel with selected studies on individual ingredients or related forms. It also identifies differences between the panel and the producer’s description that should be clarified before purchase.
Evidence status. We have not verified a clinical trial of the finished Arialief formula. Research on an individual ingredient does not establish the effectiveness of this product.
Health information and product evidence are different
The NINDS overview of pain and the NIDDK overview of diabetic neuropathy provide general medical background. Neither source evaluates Arialief or supports a claim that it relieves neuropathy symptoms.
Persistent pain, tingling, numbness or other unexplained symptoms require an appropriate clinical assessment. This advertisement does not diagnose a condition or recommend Arialief as its treatment.
What does the supplied ingredient panel list?
The ingredient panel supplied with this page lists magnesium, alpha-lipoic acid, butcher’s broom, L-carnitine, turmeric extract and coenzyme Q10. This describes the supplied panel, not confirmation of the formula currently sold.
Some names refer to botanical ingredients; others describe nutrients or compounds included in the formulation. The source image identifies the following forms:
Composition source: the ingredient-panel image supplied for this page. Check the current package label with the merchant before purchasing, as product versions and descriptions can differ. This panel documents listed ingredients; it is not a clinical study.
Research & limitations
Scientific studies on individual ingredients
Researchers have studied some of these ingredients, or related forms, in specific patient populations. Below are selected human trials, including mixed and negative findings. This is an educational source guide, not a systematic review or clinical evidence for the finished Arialief product.
Check the formula first. The producer’s page, checked September 13, 2026, mentions palmitoylethanolamide (PEA), which does not appear on the ingredient-panel image supplied for this article. That panel lists a 575 mg proprietary blend without individual amounts for most ingredients. We cannot confirm that the current product matches the forms or doses below. Ask the merchant for the current Supplement Facts before purchasing.
Dates below are publication years. Research doses describe the trials and are not instructions for taking supplements. None of these studies tests the finished Arialief formula.
01 · Magnesium · Different form; no clear pain benefit
Oral magnesium in neuropathic pain
Pickering et al., 2011 · Clermont-Ferrand, France. A randomized, placebo-controlled trial followed 45 patients for four weeks using magnesium chloride. Pain scores did not differ significantly between groups.
Limit: This trial used magnesium chloride, not the magnesium glycinate listed on the supplied panel. It does not demonstrate that Arialief relieves neuropathic pain.
Read the magnesium trial · PubMed 21659058 ↗02 · Alpha-lipoic acid · Mixed findings
Short-term symptoms and longer-term outcomes
Ziegler et al., 2006 · SYDNEY 2, Russia and Israel. In 181 patients with diabetic neuropathy, 600, 1,200 or 1,800 mg of oral alpha-lipoic acid daily improved a combined symptom score compared with placebo over five weeks. Adverse effects increased with dose.
Read SYDNEY 2 · PubMed 17065669 ↗Ziegler et al., 2011 · NATHAN 1, U.S., Canada and Europe. In 460 patients followed for four years, 600 mg daily did not significantly improve the primary combined outcome compared with placebo, although some secondary measures improved.
Read NATHAN 1 · PubMed 21775755 ↗Limit: Different outcomes and durations give a mixed picture. Arialief’s individual alpha-lipoic acid dose is not disclosed on the supplied panel; these results cannot establish its effectiveness.
03 · Butcher’s broom · Different condition
Ruscus extract for venous leg symptoms
Vanscheidt et al., 2002 · German research team, Bad Krozingen affiliation. A 12-week placebo-controlled trial enrolled 166 women with chronic venous insufficiency. A specific Ruscus extract reduced leg swelling and some venous symptoms.
Limit: Venous insufficiency is a circulation disorder; this was not a trial of neuropathy treatment. It cannot substantiate relief of nerve pain, tingling or electric-shock sensations.
Read the Ruscus trial · PubMed 12040966 ↗04 · L-carnitine · Related compound studied
Acetyl-L-carnitine in diabetic neuropathy
Sima et al., 2005 · Lead affiliation: Wayne State University, Detroit, U.S. An analysis of two 52-week placebo-controlled trials included 1,257 patients. Acetyl-L-carnitine was studied at 500 or 1,000 mg three times daily. Pain improved in one trial and in the combined higher-dose group.
Limit: Acetyl-L-carnitine is a different form from the L-carnitine named on the supplied panel. The findings and studied doses cannot be transferred directly to Arialief.
Read the acetyl-L-carnitine analysis · PubMed 15616239 ↗05 · Turmeric · Different formulation; conflicting results
Nanocurcumin trials do not give a consistent answer
Asadi et al., 2019 · Iranian university research team. An eight-week placebo-controlled trial in 80 people with diabetic neuropathy reported improvement in a combined neuropathy score with 80 mg of nanocurcumin daily.
Read the 2019 trial · PubMed 30935539 ↗Mansour et al., 2025 · Tehran University of Medical Sciences, Iran. A later 16-week placebo-controlled trial randomized 97 patients to nanocurcumin, 40 mg twice daily, or placebo. It did not find a significant benefit for pain or neuropathy outcomes.
Read the 2025 trial · PubMed 40682175 ↗Limit: Nanocurcumin has a specific delivery formulation and is not interchangeable with ordinary turmeric extract. These conflicting results do not establish an Arialief benefit.
06 · Coenzyme Q10 · Studied alongside prescription treatment
CoQ10 as an addition to pregabalin
Amini et al., 2022 · Hamadan University of Medical Sciences, Iran. In an eight-week randomized trial of 112 patients with painful diabetic neuropathy, CoQ10 at 100 mg every eight hours plus pregabalin at 150 mg daily improved pain and sleep interference compared with placebo plus pregabalin.
Limit: Both groups received prescription treatment. The trial did not establish CoQ10 as a stand-alone treatment and did not test Arialief or its blend.
Read the CoQ10 adjunct trial · PubMed 36273066 ↗07 · PEA · Mentioned by producer; formula unconfirmed
A specific palmitoylethanolamide formulation
Emily Pickering et al., 2022 · Australian research team, University of Queensland affiliations. A single-centre, placebo-controlled trial enrolled 70 people with diabetic peripheral neuropathic pain. A specific PEA formulation at 600 mg daily for eight weeks improved several pain measures compared with placebo.
Limit: PEA appears in the producer’s page copy but not on the panel supplied here. Its presence and amount in the current Arialief product remain unconfirmed. This trial cannot validate the product’s formula.
Read the PEA trial · PubMed 36057884 ↗What these studies mean for a purchase: Ingredient research can inform questions for a clinician, but it does not establish that Arialief will relieve neuropathy symptoms. We have not verified a clinical trial of the finished product. Review the current label and discuss persistent symptoms with a qualified healthcare professional.
Sources reviewed September 13, 2026. PubMed indexes research; inclusion is not an NIH endorsement of a supplement. See our references and disclosures.
What to verify before choosing a supplement
An ingredient list is only part of a supplement assessment. Confirm the current formula and amounts, then review them with a qualified healthcare professional in the context of your medications and health circumstances.
A longer ingredient list does not, by itself, establish a better result. Research about a single ingredient also cannot automatically be applied to a finished product. This article does not present a clinical study demonstrating that Arialief treats neuropathy or repairs damaged nerves.
Bring the current product label to that conversation. Product descriptions, ingredient studies and purchase policies answer different questions; none should be treated as a substitute for a clinical assessment.
Considering Arialief? Review the formula, then the offer
For a shopper interested in a capsule format, Arialief brings the listed ingredients into a single product. There is no kitchen mixture to prepare from this article. Follow the directions on the bottle you receive and professional advice relevant to you.
The practical comparison now becomes the package: how many bottles you want to buy, what the total charge will be, and the terms that come with the order. A larger package has a lower advertised price per bottle, but also a higher total purchase price.
Ready to compare the packages?
View Arialief offersProduct offer
Choose the package that fits your budget
Compare the advertised package prices below. Each button opens the corresponding Arialief merchant checkout, where you can review the final order before paying.
Smaller package
2 bottles
Product total: $158 USD
Shipping calculated at checkout.
View 2-bottle checkout →Mid-size package
3 bottles
Product total: $207 USD
Free shipping advertised; confirm destination eligibility.
View 3-bottle checkout →Lowest listed price per bottle
6 bottles
Product total: $294 USD
Free shipping advertised; confirm destination eligibility.
View 6-bottle checkout →Price source: Arialief’s merchant offer, checked September 13, 2026. Prices are in USD. Taxes and any shipping charges are additional where applicable. Offers may change. The seller describes one-time purchases; check the final billing terms before authorizing payment. No subscription or repeat order is authorized by clicking these links.
The seller advertises a 60-day satisfaction promise, subject to return requirements. This is a return policy, not a promise of health results. Read the refund information before ordering.
A few questions before you order
Is the current formula confirmed?
The supplied panel and the producer’s description differ. Ask the merchant for the current Supplement Facts, including ingredient forms and amounts, before purchasing.
Do these studies test Arialief?
This article does not verify that Arialief relieves foot pain, tingling, burning or electric-shock sensations. An ingredient list alone cannot establish that effect. Discuss symptom-management options and the current product label with a qualified healthcare professional.
Where do I complete my purchase?
The package buttons lead to the Arialief Cartpanda checkout. Review the seller, order quantity, full charge, shipping and applicable terms before paying.
Can I take it with my medications?
Do not assume a supplement is suitable for you or compatible with medicines. Ask your physician or pharmacist to review the current label and your medications before use.